| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 68.848 | 138.858 | 96.130 | 53.984 | 8.215 |
| Total Income - EUR | - | - | - | - | - | 68.848 | 138.859 | 129.544 | 53.984 | 8.215 |
| Total Expenses - EUR | - | - | - | - | - | 65.928 | 137.883 | 145.683 | 58.008 | 7.836 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.920 | 976 | -16.140 | -4.024 | 379 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.073 | -413 | -16.954 | -4.537 | 231 |
| Employees | - | - | - | - | - | 3 | 8 | 3 | 2 | 1 |
Check the financial reports for the company - Asy Medical Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 29.864 | 88.360 | 16.238 | 8.178 | 5.621 |
| Inventories | - | - | - | - | - | 8.793 | 21.338 | 6.044 | 866 | 0 |
| Receivables | - | - | - | - | - | 173 | 5.100 | 5.608 | 2.634 | 2.259 |
| Cash | - | - | - | - | - | 20.898 | 61.921 | 4.586 | 4.677 | 3.362 |
| Shareholders Funds | - | - | - | - | - | 2.077 | 1.619 | -15.330 | -19.821 | -19.479 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 27.786 | 86.741 | 31.569 | 27.999 | 25.100 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Asy Medical Pharma S.r.l.